CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Dec. 31, 2016	Dec. 31, 2015
Current assets
Cash	$ 9,375	$ 8,854
Prepaid drug product for testing	376	560
Other current assets	902	179
Total current assets	10,653	9,593
Fixed assets
Furniture, fixtures & equipment	708	123
Less accumulated depreciation	(94)	(51)
Property, Plant and Equipment, Net	614	72
Other assets
Technology licenses	2,500	2,500
Less accumulated amortization	(1,571)	(1,410)
Intangible Assets, Net (Excluding Goodwill), Total	929	1,090
Total Assets	12,196	10,755
Current liabilities
Accounts payable	69	54
Accrued expense	969	883
Deferred revenue	12	0
Total current liabilities	1,050	937
Warrant liability	2,906	0
Total Liabilities	3,956	937
Shareholders' equity
Preferred stock, $.001 par value 10,000,000 shares authorized, no shares issued and outstanding	0	0
Common stock, $.001 par value, 200,000,000 shares authorized 95,645,224 and 89,762,872 shares issued and outstanding as of 12/31/16 and 12/31/15, respectively	96	90
Additional paid in capital	40,278	35,112
Accumulated deficit	(32,134)	(25,384)
Total shareholders' equity	8,240	9,818
Total Liabilities & Shareholders' Equity	$ 12,196	$ 10,755